CIK: 0001839948 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $1,180,307 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY, INC. | 3,670,206 | $138,477 | 11.7% | $40.67 | -13.8% | COMM | 156944100 |
| DYN | DYNE THERAPEUTICS, INC | 2,650,150 | $95,193 | 8.1% | $16.62 | +139.5% | COMM | 26818M108 |
| COGT | COGENT BIOSCIENCES INC | 6,964,375 | $75,215 | 6.4% | $9.05 | +7.6% | COMM | 19240Q201 |
| ABVX | Abivax SA | 6,056,596 | $69,772 | 5.9% | $12.76 | — | ADRS | 00370M103 |
| EWTX | EDGEWISE THERAPEUTICS, INC. | 2,112,984 | $56,396 | 4.8% | $15.89 | +25.2% | COMM | 28036F105 |
| SLN | SILENCE THERAPEUTICS PLC | 3,033,560 | $55,150 | 4.7% | $14.21 | — | ADRS | 82686Q101 |
| SVRA | SAVARA INC. | 12,362,205 | $52,416 | 4.4% | $3.73 | +18.3% | COMM | 805111101 |
| KROS | KEROS THERAPEUTICS, INC. | 879,344 | $51,064 | 4.3% | $59.30 | -16.7% | COMM | 492327101 |
| XNCR | XENCOR INC | 2,427,138 | $48,810 | 4.1% | $18.77 | 0.0% | COMM | 98401F105 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $46,764 | 4.0% | $12.71 | +65.2% | COMM | 90240B106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,063,000 | $46,655 | 4.0% | $43.45 | — | ADRS | 86366E106 |
| OCUL | OCULAR THERAPEUTIX, INC. | 5,319,148 | $46,277 | 3.9% | $7.10 | +16.1% | COMM | 67576A100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,890,816 | $46,224 | 3.9% | $7.22 | — | COMM | 152309100 |
| — | TOURMALINE BIO INC | 1,477,593 | $37,989 | 3.2% | $25.14 | — | COMM | 89157D105 |
| — | THIRD HARMONIC BIO INC | 2,415,000 | $32,723 | 2.8% | $13.55 | — | COMM | 88427A107 |
| — | ASTRIA THERAPEUTICS, INC. | 2,761,861 | $30,408 | 2.6% | $14.07 | — | COMM | 04635X102 |
| MLYS | MINERALYS THERAPEUTICS, INC. | 2,470,265 | $29,915 | 2.5% | $12.35 | -2.0% | COMM | 603170101 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $27,818 | 2.4% | $14.54 | +39.3% | COMM | 50127T109 |
| SLNO | SOLENO THERAPEUTIVS, INC. | 550,000 | $27,770 | 2.4% | $47.87 | 0.0% | COMM | 834203309 |
| CMPS | COMPASS PATHWAYS PLC | 3,858,000 | $24,305 | 2.1% | $7.40 | — | ADRS | 20451W101 |
| IRON | Disc Medicine, Inc. | 486,957 | $23,929 | 2.0% | $33.98 | +38.2% | COMM | 254604101 |
| FULC | FULCRUM THERAPEUTICS INC | 5,250,000 | $18,743 | 1.6% | $7.42 | 0.0% | COMM | 359616109 |
| MBX | MBX BIOSCIENCES INC | 650,000 | $16,887 | 1.4% | $22.87 | 0.0% | COMM | 55287L101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 4,643,812 | $15,046 | 1.3% | $2.25 | 0.0% | COMM | 03237H101 |
| — | ADVERUM BIOTECHNOLOGIES, INC. | 2,008,339 | $14,099 | 1.2% | $7.02 | — | COMM | 00773U207 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $9,348 | 0.8% | $17.12 | — | COMM | 29384C108 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,676,580 | $8,057 | 0.7% | $3.41 | 0.0% | COMM | 92840H400 |
| TARS | TARSUS PHARMACEUTICALS, INC. | 231,820 | $7,625 | 0.6% | $17.70 | +58.8% | COMM | 87650L103 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 922,335 | $7,369 | 0.6% | $13.97 | -37.1% | COMM | 30233G209 |
| — | NEKTAR THERAPEUTICS | 4,000,000 | $5,200 | 0.4% | $0.93 | — | COMM | 640268108 |
| — | AEROVATE THERAPEUTICS INC | 2,240,809 | $4,683 | 0.4% | $15.50 | — | COMM | 008064107 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $4,589 | 0.4% | $10.31 | 0.0% | COMM | 05338F306 |
| KOD | KODIAK SCIENCES INC | 1,008,158 | $2,631 | 0.2% | $3.95 | -32.7% | COMM | 50015M109 |
| ANTX | AN2 Therapeutics, Inc. | 1,555,118 | $1,664 | 0.1% | $9.33 | -81.4% | COMM | 037326105 |
| VTYX | VENTYX BIOSCIENCES, INC | 316,195 | $689 | 0.1% | $29.94 | -92.3% | COMM | 92332V107 |
| CABA | CABALETTA BIO, INC | 86,795 | $410 | 0.0% | $3.64 | +58.9% | COMM | 12674W109 |